IR Conference Call for 2025 Q4 and Annual Earnings
- IR conference call for 2025 Q4 and annual (preliminary) earnings release
- Date: 2026-02-06 10:30, via conference call
- Includes R&D session; materials posted on website and live audio webcasting
ADVERTISEMENT (250px+)
KOSPI Filing Information
- Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
- Company: SK Biopharmaceuticals (326030)
- Submission: SK Biopharmaceuticals Co., Ltd.
- Receipt: 02-03-2026
- Under KRX KOSPI Market Division